OBJECTIVES: The aim of this study was to determine if red cell distribution width (RDW) could improve the prediction of prognosis after transcatheter aortic valve implantation (TAVI).
INTRODUCTION
Aortic valve stenosis is the most common acquired valvular heart disease in the elderly. Despite advances in cardiac surgery and low mortality rates after conventional surgical aortic valve replacement, up to one-third of patients with symptomatic aortic valve stenosis are not considered for surgical valve replacement, often due to age, frailty or comorbidities [1] . Recently, transcatheter aortic valve implantation (TAVI) has been proved to be a reasonable alternative for the treatment of severe, symptomatic aortic stenosis in elderly high-risk patients [2] [3] [4] .
Patient selection for this less invasive technique depends on the multidisciplinary heart team discussion, where technical aspects of the procedure are evaluated, together with the procedural risk estimation of the patient. Whereas surgical risk scores [European System for Cardiac Operative Risk Evaluation (EuroSCORE): logistic EuroSCORE (LES), EuroSCORE II (ES II) and the Society of Thoracic Surgeons (STS) score] could guide patient selection, they are limited by the absence of considering specific TAVI-related risk factors (e.g. frailty), not being based on elderly patient cohorts (≥75 years) and in general not being accurate enough to predict individual prognosis after TAVI [5, 6] . Development of more TAVI-specific risk scores, most probably also including individual biological disease markers, might therefore be of significant clinical value.
Red cell distribution width (RDW) is a measurement of the variation in size of circulating erythrocytes. Increase in RDW (or anisocytosis) is associated with increased red cell destruction, hepatic congestion, inflammation-induced bone marrow dysfunction, renal failure and iron, vitamin B12 or folate deficiency. Therefore, it has been put forward as an integrative marker for multiple chronic pathophysiological processes. Indeed, RDW has recently emerged as a powerful predictor of poor outcome in the general population, in patients with cardiovascular diseases and following cardiovascular interventions, including TAVI [7] [8] [9] [10] [11] [12] [13] [14] [15] .
The aim of this study was to determine if RDW at baseline could improve the prediction of the prognosis after TAVI.
MATERIALS AND METHODS

Study design
In this single-centre study, we included consecutive patients with severe symptomatic aortic valve stenosis, rejected for surgical aortic valve replacement as decided by the local heart team, who underwent TAVI using the Medtronic CoreValve prosthesis between December 2007 and May 2014. The study was approved by the local ethics committee of the Antwerp University Hospital.
Surgical risk scores
The LES, ES II and STS score were calculated for each patient. 'Low risk' was defined as <10%, <4%, <4%, 'medium risk' as 10-20%, 4-10%, 4-10% and 'high risk' as >20%, >10%, >10% by LES, ES II and STS score, respectively [4, 16] .
Laboratory measurements
Laboratory tests were performed within 72 h before TAVI (baseline) and at discharge. Haemoglobin, mean cellular volume and RDW were measured using an ADVIA 2120 Haematology system (Siemens Healthcare Diagnostics, Erlangen, Germany) on blood collected in ethylenediamine tetra-acetic acid tubes. Based on the finding by Aung et al. [14] , elevated RDW was defined as RDW >15.5%. Estimated glomerular filtration rate (eGFR) was calculated using the Modification of Diet in Renal Disease formula [17] .
Outcome measures
Major adverse cardiac and cerebrovascular events (MACCEs) that occurred within 30 days after the procedure were reported according to the standardized endpoints of the Valve Academic Research Consortium 2 [18] . The combined safety endpoint comprises all-cause mortality, all types of stroke, life-threatening bleeding and major vascular complications.
Medium-term survival of the patients was assessed up to 1 year after TAVI.
Statistical analysis
Data are presented as mean ± standard deviation (SD) or as median (Q1-Q3), depending on the distribution of the data. Normality was evaluated by histograms, QQ-plots and the Kolmogorov-Smirnov test. Continuous variables were tested with Student's t-test or Mann-Whitney U-tests, depending on the distribution. Categorical variables are presented as n (%) and were compared with χ 2 or Fisher's exact test. Fisher's exact test was used if at least one cell of the cross-tabs had an expected count <5. If not, the P-value of the Pearson χ 2 test was reported. Binary logistic regression was used to determine predictors for major vascular complications and grade aortic regurgitation (AR) II-IV post-TAVI. Survival was determined by recorded events and by censoring patients at 1 year. Kaplan-Meier curves were constructed for survival. Differences of survival between RDW ≤15.5% and RDW >15.5% were tested based on the log-rank test. Cox regression was used to determine predictors of mortality. First, a univariable analysis was performed, including only one parameter at a time. The statistically significant parameters in the univariable analysis (P < 0.05) are included as predictors of mortality in multivariable Cox regression. To reduce the model, the 'Forward Conditional' method was used. Collinearity of the parameters was determined by the variance inflation factor. Statistical analyses were conducted with SPSS version 20.0 (IBM Corporation, New York, USA).
RESULTS
Patients were stratified according to normal RDW (≤15.5%, n = 168) or elevated RDW (>15.5%, n = 29). Differences in baseline characteristics between these two groups are shown in Table 1 . Patients with elevated RDW had a significantly higher STS score (7.2 vs 5.0%, P = 0.041) and higher systolic pulmonary arterial pressure (50 vs 41 mmHg, P = 0.021). Haemoglobin (11.5 vs 12.4 mg/dl, P = 0.003) and eGFR (48 vs 60 ml/min/1.73 m², P = 0.059) were decreased in patients with elevated RDW. More patients with elevated RDW were in New York Heart Association functional class III-IV (89.7 vs 72.6%, P = 0.05).
Predictive value of surgical risk scores
The incidence of procedure-related MACCEs according to the three surgical risk scores is summarized in Table 2 . An ES II >10% was associated with the occurrence of major vascular complications (P = 0.006) and the need for new pacemaker (P = 0.016). The length of hospital stay was significantly higher in patients with STS score >10% (P = 0.040).
Mortality occurred in 32 patients. The predictive value of the surgical risk scores for the individual prognosis after TAVI was assessed using Cox regression (Table 3 , Fig. 1 ). Only the STS score could predict mortality, both when applied as a continuous and as a binary variable.
Predictive value of red cell distribution width
Red cell distribution width baseline and 30-day procedurerelated major adverse events. Although procedure-related MACCEs occurred more frequently in the RDW >15.5% group (Table 4) , only the occurrence of major vascular complications and the incidence of significant AR post-TAVI were significantly different between the two groups. Based on univariable binary logistic regression, RDW >15.5% was significant for major vascular complications [odds ratio Red cell distribution width baseline and survival posttranscatheter aortic valve implantation. Survival was significantly worse in patients with an elevated RDW ( Fig. 2 ): mortality occurred in 22 patients with normal RDW and in 10 patients with RDW >15.5%. Preprocedural predictors of mortality were determined by Cox regression analysis (Table 5) . No collinearity was observed between the parameters, based on the low variance inflation factors (<5), which confirmed that the predictor RDW >15.5% (hazard ratio: 2.283, P = 0.037) is independent of haemoglobin (hazard ratio: 0.809, P = 0.097), when entered into the same model. Higher age and low left ventricular ejection fraction did not predict mortality. RDW >15.5% was a significant predictor of mortality after TAVI both in univariable analysis (hazard ratio: 2.701, P = 0.009) and in multivariable analysis (hazard ratio: 2.383, P = 0.024). Apart from RDW, intake of acetylsalicylic acid was the only other variable that predicted survival. When adding RDW in a multivariable model with STS score, elevated RDW was the most significant determinant of mortality, suggesting that the predictive value of STS score could be increased by the addition of RDW (Table 4) . No differences in causes of death were found between the RDW groups.
DISCUSSION
We could demonstrate that an elevated baseline RDW was related to a more complex baseline clinical patient risk profile and that TAVI-related MACCEs occurred more frequently in the RDW >15.5% group, mainly due to the occurrence of major vascular complications or significant AR. Moreover, baseline RDW >15.5% was the most 
Elevated red cell distribution width and operative risk profile
Patients undergoing TAVI are rejected for surgical aortic valve replacement by the local heart team, because of their increased operative risk profile. This increased operative risk is not only related to technical aspects but also to age, frailty, malnutrition and specific (geriatric) comorbidities, and measurement of these patientspecific characteristics is challenging. Indeed, surgical risk scores are used to evaluate the risk profile of patients considered for TAVI, but are known to be insufficiently accurate to predict individual prognosis after TAVI [5, 6] . There is now ample evidence that red blood cells is an integrative prognostic marker in various cardiovascular diseases and in the geriatric population [7] [8] [9] [10] [11] [12] [13] 19] . Elevated RDW or anisocytosis reflects greater heterogeneity in red blood cell size, caused by the presence of circulating immature, juvenile red blood cells. This can be caused by either increased red blood cell destruction or ineffective erythropoiesis due to renal failure, hepatic congestion, inflammation-induced bone marrow dysfunction and iron, vitamin B12 or folate deficiency [8] .
In the present study, RDW was related to anaemia, chronic kidney disease and other comorbidities (Table 1) , a relation that has been described extensively [13, 20] . Therefore, increased baseline RDW could be considered to be a simple integrative biological marker, expressing an increased baseline patient risk profile.
Elevated red cell distribution width and 1-month procedural-related major adverse cardiovascular and cerebral events
We observed that patients with an elevated RDW >15.5% at baseline had significantly more post-procedural major vascular complications and significant paravalvular AR as quantified by echocardiography. Although not significant in this relatively small single-centre cohort, patients with high baseline RDW tended to Table 2 : Major adverse cardiovascular and cerebral events within 30 days after the procedure, according to the surgical risk scores have more extensive peripheral, carotid and coronary disease, potentially contributing to an increased risk of vascular complications [9, 13] . The potential relation between high baseline RDW and increased risk to develop significant AR after TAVI is intriguing. However, Aung et al. [14] made a similar observation, although not extensively discussed. In their study, 5.9% of patients with baseline RDW >15% had post-procedure significant AR, compared with only 0.8% patients with a normal RDW. We could confirm these data by careful evaluation of quantification of AR after TAVI by echocardiography. Increased risk to develop significant AR after TAVI might be related to somewhat more severe aortic valve stenosis in the high baseline RDW patient cohort. This finding needs confirmation in a larger cohort.
Elevated red cell distribution and survival up to one year
In our study, baseline RDW >15.5% was the most significant determinant of mortality, both in univariable and multivariable analysis, which confirmed the findings of Magri et al. [15] and Aung et al. [14] , but added value on the available STS score in the prediction of mortality after TAVI in our study. According to Aung et al., an observed change in RDW was a significant predictor of mortality post-TAVI. In contrast to the findings of Aung et al., this could not be confirmed in the multivariate analysis in the present study, which included other changes in laboratory parameters. RDW has demonstrated to be a predictor of poor prognosis in other patient populations [7-13, 19, 20] .
Relevance to clinical practice
The current study might have important implications in daily clinical practice and care for patients with severe aortic valve stenosis. Since the classical surgical risk scores are not accurate enough to predict individual prognosis after TAVI, the need for development of more TAVI-specific risk scores, including individual biological disease markers, is mandatory. The abovementioned observations, together with an elevated RDW at baseline expressing worse baseline characteristics and worse outcomes post-TAVI and the fact that RDW >15.5% could improve the STS score in the prediction of mortality after TAVI, point towards RDW being a potential biomarker of the overall health condition in this specific older patient cohort [7, 19] . RDW could be a potential biomarker of frailty, defined as a decline in overall function and loss of resistance to stressors of this group of patients at high risk for surgical aortic valve replacement. The fact that RDW is an inexpensive and readily available marker adds to its potential to be included in future risk stratification assessments.
Further research is necessary to validate RDW as a prognosis marker in larger TAVI populations and to correlate RDW and nutritional laboratory parameters to geriatric characteristics of these patients. In this way, RDW could be helpful in the set-up of specific TAVI scores to (i) allow proper, standardized selection of TAVI patients and (ii) to estimate the risk of mortality during/after TAVI.
LIMITATIONS OF THE STUDY
This study was based on a single-centre TAVI population, including a limited number of patients, especially in the elevated RDW group. Besides RDW, various other parameters were tested, which could lead to multiplicity problems. However, the focus was laid especially on RDW; therefore, no correction for multiplicity problems was performed. No laboratory parameters were available to evaluate erythropoiesis and nutritional state of the patients undergoing TAVI. Systemic evaluation of the frailty status of these patients was missing. To provide a proper predictive model including more parameters, more events are needed, which could be established by setting up a multicentre study and elongating the follow-up.
CONCLUSION
Patients with elevated RDW at baseline who underwent TAVI had worse characteristics at baseline and worse outcomes post-TAVI. Baseline RDW >15.5% could improve the available surgical risk score (STS score) in the prediction of mortality after TAVI. Baseline RDW should be taken into account in the development of a specific TAVI risk score. 
